Total Payments
$556.76
2024 Payments
$23.71
Companies
7
Transactions
12
Medicare Patients
7,793
Medicare Billing
$282,993
Payment Breakdown by Category
Food & Beverage$556.76 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $556.76 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $328.33 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $64.84 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $53.21 | 3 | $0 (2024) |
| Lantheus Medical Imaging, Inc. | $40.44 | 2 | $0 (2019) |
| HeartFlow, Inc. | $33.06 | 1 | $0 (2023) |
| Amarin Pharma Inc. | $23.91 | 1 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.97 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.71 | 1 | Novartis Pharmaceuticals Corporation ($23.71) |
| 2023 | $444.38 | 6 | Abbott Laboratories ($328.33) |
| 2020 | $23.91 | 1 | Amarin Pharma Inc. ($23.91) |
| 2019 | $64.76 | 4 | Lantheus Medical Imaging, Inc. ($40.44) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $50.80 | General |
| Category: Cardiovascular | ||||||
| 11/08/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.04 | General |
| Category: Cardiovascular | ||||||
| 07/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $33.06 | General |
| Category: Coronary | ||||||
| 03/06/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $185.29 | General |
| Category: Heart Failure | ||||||
| 03/06/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $143.04 | General |
| Category: Heart Failure | ||||||
| 02/18/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Cardiovascular | ||||||
| 10/14/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2019 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Contrast Agent | ||||||
| 09/24/2019 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Contrast Agent | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,007 | 2,177 | $237,640 | $71,361 |
| 2022 | 24 | 1,802 | 1,938 | $201,344 | $63,099 |
| 2021 | 25 | 2,195 | 2,461 | $247,307 | $82,198 |
| 2020 | 22 | 1,789 | 1,914 | $201,983 | $66,336 |
Total Patients
7,793
Total Services
8,490
Medicare Billing
$282,993
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 342 | 346 | $55,706 | $17,804 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 93 | $20,724 | $8,091 | 39.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 131 | 131 | $21,506 | $5,984 | 27.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 71 | $10,863 | $4,427 | 40.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 62 | 62 | $11,780 | $3,474 | 29.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 43 | 43 | $11,180 | $3,411 | 30.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $9,389 | $3,284 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $5,874 | $2,452 | 41.7% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 15 | 15 | $8,310 | $2,413 | 29.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 235 | 299 | $7,774 | $1,804 | 23.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 19 | $4,123 | $1,782 | 43.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 23 | 23 | $6,923 | $1,777 | 25.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 30 | 30 | $5,700 | $1,648 | 28.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 73 | 77 | $6,391 | $1,400 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,858 | $1,369 | 28.2% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 2023 | 160 | 218 | $5,668 | $1,338 | 23.6% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Facility | 2023 | 14 | 14 | $2,786 | $966.28 | 34.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 89 | 89 | $4,361 | $940.84 | 21.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 57 | 57 | $3,990 | $880.50 | 22.1% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 16 | 16 | $3,504 | $835.72 | 23.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 55 | 55 | $4,675 | $734.05 | 15.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 11 | 11 | $2,343 | $522.96 | 22.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 49 | 49 | $2,401 | $516.62 | 21.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 55 | $2,805 | $494.70 | 17.6% |
| 93319 | 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | Facility | 2023 | 24 | 24 | $1,248 | $455.28 | 36.5% |
About Dr. David Cameron, MD
Dr. David Cameron, MD is a Internal Medicine healthcare provider based in Wyoming, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2013. The National Provider Identifier (NPI) number assigned to this provider is 1720425788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Cameron, MD has received a total of $556.76 in payments from pharmaceutical and medical device companies, with $23.71 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($556.76).
As a Medicare-enrolled provider, Cameron has provided services to 7,793 Medicare beneficiaries, totaling 8,490 services with total Medicare billing of $282,993. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Wyoming, MI
- Active Since 05/31/2013
- Last Updated 02/19/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720425788
Products in Payments
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $328.33
- ELIQUIS (Drug) $50.80
- LEQVIO (Drug) $41.86
- Definity (Drug) $40.44
- FFRct (Device) $33.06
- Vascepa (Drug) $23.91
- CAMZYOS (Drug) $14.04
- PRADAXA (Drug) $12.97
- ENTRESTO (Drug) $11.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wyoming
Mounir Ghali, M.d, M.D
Internal Medicine — Payments: $363,968
Internal Medicine $363,968
Dr. Michael Sumners, D.o, D.O
Internal Medicine — Payments: $9,438
Internal Medicine $9,438
Dr. Gunjan Gholkar, M.d, M.D
Internal Medicine — Payments: $7,082
Internal Medicine $7,082
David Tabor, Do, DO
Internal Medicine — Payments: $6,045
Internal Medicine $6,045
Dr. Soheil Assar, Do, DO
Internal Medicine — Payments: $2,492
Internal Medicine $2,492
Dr. Lucas Watts, D.o, D.O
Internal Medicine — Payments: $1,807
Internal Medicine $1,807